Evidence map›Paper›PMID 34888651›Full record

ArticleRheumatology (Oxford, England)2022

Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA.

Johanna Dahlqvist, Diana Ekman, Bengt Sennblad, Sergey V Kozyrev, Jessika Nordin, Åsa Karlsson, Jennifer R S Meadows, Erik Hellbacher, Solbritt Rantapää-Dahlqvist, Ewa Berglin and 25 more

Open access · bronzeAbstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. PeerJ · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Association ofFrontiers in immunology · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 15 institutions in 5 countries.

Johanna DahlqvistDepartment of Medical Sciences.ORCID 0000-0002-6283-644X
Diana EkmanDepartment of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Stockholm University, Stockholm.
Bengt SennbladDepartment of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala.
Sergey V KozyrevScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Jessika NordinScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Åsa KarlssonScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Jennifer R S MeadowsScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Erik HellbacherDepartment of Medical Sciences.
Solbritt Rantapää-DahlqvistDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.ORCID 0000-0001-8259-3863
Ewa BerglinDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Bernd StegmayrDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Bo BaslundCopenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Øyvind PalmDepartment of Rheumatology, Oslo University Hospital.
Hilde HaukelandDepartment of Rheumatology, Martina Hansens Hospital, Oslo, Norway.
Iva GunnarssonDepartment of Medicine, Division of Rheumatology, Karolinska Institutet, Stockholm.
Annette BruchfeldDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping.ORCID 0000-0002-9752-9941
Mårten SegelmarkDepartment of Clinical Sciences, Division of Nephrology, Lund University and Skåne University Hospital.
Sophie OhlssonDepartment of Clinical Sciences, Division of Nephrology, Lund University and Skåne University Hospital.
Aladdin J MohammadDepartment of Clinical Sciences Lund, Section of Rheumatology, Skåne University Hospital, Lund University, Lund, Sweden.ORCID 0000-0002-7169-6936
Anna SvärdCenter for Clinical Research Dalarna, Uppsala University, Uppsala.
Rille PulleritsDepartment of Rheumatology and Inflammation Research, Institution of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg.
Hans HerlitzDepartment of Molecular and Clinical Medicine/Nephrology, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg.
Annika SöderberghDepartment of Rheumatology, Örebro University Hospital, Örebro, Sweden.
Gerli Rosengren PielbergScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Lina Hultin RosenbergScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Matteo BianchiScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Eva MurénScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Roald OmdalClinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger.
Roland JonssonBroegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
Maija-Leena ElorantaDepartment of Medical Sciences.
Lars RönnblomDepartment of Medical Sciences.
Peter SöderkvistDepartment of Biomedical and Clinical Sciences, Division of Cell Biology.
Ann KnightDepartment of Medical Sciences.
Per ErikssonDepartment of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden.
Kerstin Lindblad-TohScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Uppsala University · SELund University · SEUmeå University · SEBroad Institute · USLinköping University · SECopenhagen University Hospital · DKKarolinska University Hospital · SEMartina Hansens Hospital · NOÖrebro University Hospital · SEOslo University Hospital · NOSahlgrenska University Hospital · SEStavanger University Hospital · NOStockholm University · SEUniversity of Bergen · NOUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify and characterize genetic loci associated with the risk of developing ANCA-associated vasculitides (AAV).

methodsGenetic association analyses were performed after Illumina sequencing of 1853 genes and subsequent replication with genotyping of selected single nucleotide polymorphisms in a total cohort of 1110 Scandinavian cases with granulomatosis with polyangiitis or microscopic polyangiitis, and 1589 controls. A novel AAV-associated single nucleotide polymorphism was analysed for allele-specific effects on gene expression using luciferase reporter assay.

resultsPR3-ANCA+ AAV was significantly associated with two independent loci in the HLA-DPB1/HLA-DPA1 region [rs1042335, P = 6.3 × 10-61, odds ratio (OR) 0.10; rs9277341, P = 1.5 × 10-44, OR 0.22] and with rs28929474 in the SERPINA1 gene (P = 2.7 × 10-10, OR 2.9). MPO-ANCA+ AAV was significantly associated with the HLA-DQB1/HLA-DQA2 locus (rs9274619, P = 5.4 × 10-25, OR 3.7) and with a rare variant in the BACH2 gene (rs78275221, P = 7.9 × 10-7, OR 3.0), the latter a novel susceptibility locus for MPO-ANCA+ granulomatosis with polyangiitis/microscopic polyangiitis. The rs78275221-A risk allele reduced luciferase gene expression in endothelial cells, specifically, as compared with the non-risk allele.

conclusionWe identified a novel susceptibility locus for MPO-ANCA+ AAV and propose that the associated variant is of mechanistic importance, exerting a regulatory function on gene expression in specific cell types.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGranulomatosis with PolyangiitisMicroscopic PolyangiitisAntibodies, Antineutrophil CytoplasmicEndothelial CellsHumansMyeloblastinPeroxidaseAntibodies, Antineutrophil CytoplasmicMyeloblastinPeroxidaseANCA-associated vasculitisBACH2genetic analysisMPO-ANCAPR3-ANCAregulatory variant

Identifiers

PMID34888651
PMCPMC9348767
OpenAlexW4200138816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.